Printed from Voxsanity (voxsanity.com.au) — NCT06138028 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Oesophageal Cancer
Phase 3 Oesophageal Cancer Trial, Recruiting
NCT06138028
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Stage IV squamous cell carcinoma (a specific type of cancer) of the esophagus (the tube connecting your throat to your stomach)
- Doctors expect you to live for at least 3 months or more
- You have at least one tumor that can be measured on a scan, following specific measurement guidelines used in research
- You are generally able to carry out daily activities with little or no difficulty (based on a standard fitness score of 0 or 1 used by doctors)
- Your bone marrow is producing enough blood cells — your white blood cells, platelets, and red blood cells are at acceptable levels (confirm with trial site)
- Your liver is functioning well enough, based on blood test results within certain limits (confirm with trial site)
- Your kidneys are working well enough, based on blood tests or a kidney function calculation (confirm with trial site)
- Your urine protein levels are within acceptable limits (confirm with trial site)
- Your heart is pumping blood effectively, with the heart's pumping strength at 50% or above
- Your blood clotting levels are within acceptable ranges based on specific blood tests (confirm with trial site)
Who may not be able to join:
- You have a known or suspected history of active autoimmune diseases — conditions where your immune system attacks your own body, such as certain types of lung inflammation, colitis, hepatitis, or thyroid problems (among others)
- You have a history of a weakened immune system, are HIV positive, have another condition that affects your immune system, or have had an organ or bone marrow transplant in the past
- You have serious lung conditions, such as interstitial lung disease or significant breathing problems, or are currently taking steroid medicines for a lung condition
- You have heart problems that are not well controlled, such as significant heart failure, unstable chest pain (angina), a heart attack within the past 24 weeks, or certain irregular heart rhythms that require treatment
- You have a hereditary bleeding disorder or a tendency to bleed, or you have had significant bleeding (such as from the stomach or gut) in the 3 months before joining the trial
- You are allergic to any of the medicines being used in this trial
- You are pregnant or currently breastfeeding
- The doctor running the trial feels, for any reason, that it would not be appropriate for you to take part (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Phase 3
Sponsor
Qingdao Central Hospital
Registry
ClinicalTrials.gov
Start date
20 September 2023
Est. completion
31 October 2025
Where this trial is recruiting
🇨🇳 China
Primary endpoints
Overall survival (OS); Progression-free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.